Structure Therapeutics (GPCR) Assets Average (2023 - 2026)

Structure Therapeutics' Assets Average history runs 4 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Assets Average rose 74.7% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 74.7% YoY), while the FY2025 annual figure was $1.2 billion, up 79.54% from the prior year.
• Assets Average for Q1 2026 stood at $1.5 billion, up from $1.2 billion in the prior quarter.
• The five-year high for Assets Average was $1.5 billion in Q1 2026, with the low at $172.6 million in Q1 2023.
• The 4-year median for Assets Average is $824.3 million (2025), against an average of $716.8 million.
• The sharpest annual moves came in 2024 and 2025: Assets Average surged 321.77% in 2024, then dropped 12.32% in 2025.
• Structure Therapeutics' Assets Average stood at $349.2 million in 2023, then surged by 162.97% to $918.3 million in 2024, then soared by 31.56% to $1.2 billion in 2025, then advanced by 27.98% to $1.5 billion in 2026.
• Business Quant data shows GPCR's Assets Average at $1.5 billion in Q1 2026, $1.2 billion in Q4 2025, and $824.3 million in Q3 2025.